Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1437.05 8.65 (0.61%) | NSE 1439.60 10.30 (0.72%) | Trade | Add

BSE Live

Dec 03, 15:20

1437.05 8.65 (0.61%)

Volume

AVERAGE VOLUME

5-Day

123,216

10-Day

76,686

30-Day

41,394

4,768

Prev. Close

1428.40
Open Price

1435.30

Bid Price (Qty.)
1436.55 (22)
Offer Price (Qty.)
1440.35 (6)

NSE Live

Dec 03, 15:20

1439.60 10.30 (0.72%)

Volume

AVERAGE VOLUME

5-Day

203,420

10-Day

211,377

30-Day

343,185

138,392

Prev. Close

1429.30
Open Price

1439.80

Bid Price (Qty.)
1439.00 (12)
Offer Price (Qty.)
1440.00 (65)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Ipca Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	6,639.52	6,121.79	5,777.18	5,336.38	5,085.19
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	6,639.52	6,121.79	5,777.18	5,336.38	5,085.19
Total Operating Revenues	6,677.92	6,166.46	5,814.62	5,399.36	5,139.16
Other Income	71.29	111.29	111.19	56.13	62.24
Total Revenue	6,749.21	6,277.75	5,925.81	5,455.49	5,201.40
EXPENSES
Cost Of Materials Consumed	1,417.64	1,688.36	1,684.03	1,600.98	1,555.53
Purchase Of Stock-In Trade	347.24	345.21	280.91	282.90	197.68
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	128.43	-55.19	104.09	-120.76	-170.73
Employee Benefit Expenses	1,479.34	1,336.19	1,193.39	1,089.63	948.84
Finance Costs	63.04	120.67	43.92	7.21	8.14
Depreciation And Amortisation Expenses	251.97	246.48	228.63	204.10	187.72
Other Expenses	1,780.24	1,640.51	1,640.35	1,303.07	1,094.26
Total Expenses	5,467.90	5,322.23	5,175.32	4,367.13	3,821.44
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,281.31	955.52	750.49	1,088.36	1,379.96
Exceptional Items	-281.54	-133.36	0.00	0.00	0.00
Profit/Loss Before Tax	999.77	822.16	750.49	1,088.36	1,379.96
Tax Expenses-Continued Operations
Current Tax	341.63	291.00	223.95	197.20	244.98
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.11	3.74	20.84	20.14	-5.79
Tax For Earlier Years	-0.73	-2.99	0.00	0.08	0.00
Total Tax Expenses	349.01	291.75	244.79	217.42	239.19
Profit/Loss After Tax And Before ExtraOrdinary Items	650.76	530.41	505.70	870.94	1,140.77
Profit/Loss From Continuing Operations	650.76	530.41	505.70	870.94	1,140.77
Profit/Loss For The Period	650.76	530.41	505.70	870.94	1,140.77
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	36.75	26.16	19.93	34.33	90.08
Diluted EPS (Rs.)	25.65	20.91	19.93	34.33	90.08
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	101.48	50.74	101.48	101.48	101.48
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	400.00	400.00	400.00	400.00	400.00